Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroinflammatory Diseases × Dexmedetomidine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Delirium 2 Central Nervous System Diseases 2 Supratentorial Neoplasms 1 Spinal Cord Neoplasms 1 Neuroinflammatory Diseases 1 Neurofibromatoses 1 Neurocognitive Disorders 1 Neoplasms 1 Intracranial Aneurysm 1 Hypoxia 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Emergence Delirium 1 Cerebrovascular Disorders 1 Abdominal Neoplasms 1

Interventions

Sodium Chloride 1 Saline Solution 1 Mn-PyC3A 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04266665 2025-11-28

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡